Ziopharm Oncology Announces Publication of Positive Results of Phase 1 Monotherapy Trial of Controlled IL-12 in Patients with Recurrent Glioblastoma in Science Translational Medicine

Wall Street Business News

Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow